Talecris Biotherapeutics Holdings Corp. 4/A
4/A · Talecris Biotherapeutics Holdings Corp. · Filed Sep 17, 2010
Insider Transaction Report
Form 4/AAmended
LYNCH THOMAS J
Sr. VP, Corp. Compliance
Transactions
- Sale
Common Stock
2010-09-03$22.50/sh−131,929$2,968,403→ 2,631 total
Footnotes (3)
- [F1]The transaction reported was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 30, 2010.
- [F2]The Reporting Person is amending the Form 4 filed on September 7, 2010 with respect to the September 3, 2010 disposition transaction reported in that Form 4, to correctly report that the number of shares disposed of was 131,929 shares instead of 113,440 shares.
- [F3]The number of shares reported consists of restricted share units representing the right to receive 2,631 shares of the Issuers common stock that will vest in three equal annual installments beginning April 1, 2011, as detailed in a restricted share unit award agreement by and between the Issuer and the Reporting Person, dated as of September 30, 2009.